Understanding Freedom to Operate (FTO) Concerning IP & Patents
Kashishipr
DECEMBER 28, 2021
Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. However, in this case, it is imperative to note that determining the scope of a patent is not easy. Bottom Line.
Let's personalize your content